A citation-based method for searching scientific literature




Marcus Lind, Ann-Marie Svensson, Mikhail Kosiborod, Soffia Gudbjörnsdottir, Aldina Pivodic, Hans Wedel, Sofia Dahlqvist, Mark Clements, Annika Rosengren. N Engl J Med 2014
Times Cited: 417




List of shared articles



Times cited

Investigating potential protein markers of cardiovascular disease in children with type 1 diabetes mellitus.
Natasha Letunica, Tengyi Cai, Fergus Cameron, Paul Monagle, Vera Ignjatovic, Chantal Attard. Proteomics Clin Appl 2021
0

Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk.
Cristina Colom, Anna Rull, José Luis Sanchez-Quesada, Antonio Pérez. J Clin Med 2021
0

Treatment strategies for hypertension in patients with type 1 diabetes.
Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Alexandros Sachinidis, Michalis Doumas, Vasilios G Athyros. Expert Opin Pharmacother 2020
1

Overweight and obesity in type 1 diabetes equal those of the general population.
Paul Fellinger, David Fuchs, Peter Wolf, Georg Heinze, Anton Luger, Michael Krebs, Yvonne Winhofer. Wien Klin Wochenschr 2019
7

Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes.
Marie-Christine Dubé, Martin D'Amours, S John Weisnagel. Diabetes Obes Metab 2018
12

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
84

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
146



Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.
Laura Brugnara, Roger Mallol, Josep Ribalta, Maria Vinaixa, Serafín Murillo, Teresa Casserras, Montse Guardiola, Joan Carles Vallvé, Susana G Kalko, Xavier Correig,[...]. PLoS One 2015
5